Skip to content
Back to news

Increased patient adherence thanks to health care professionals

Therapeutic adherence refers to the degree of agreement between the physician’s recommendations and the patient’s behavior. From a medical viewpoint, a patient is considered to be “non-adherent” if they are following less than 80% of their treatment1.

Read the opinion piece by Arnaud Lallouette: “Therapeutic adhesion, the missing piece to care for chronic diseases?

In Vietnam, patients sometimes spend hours in the waiting room before they can see a physician.

To relieve hospital congestion and offer patients better medical follow-up, Servier Vietnam in collaboration with Vietnam Heart Association, Vietnam Association of Diabetes & Endocrinology and HCM Medical University have launched a wide-ranging training program for nurses: the Ngày Dầu Tiên (“First Day”) project. Now at the heart of the health care process, nurses are responsible for consult and educate hypertensive and diabetes patients by:  

  • collecting patients’ medical information before the visit, to optimize the appointment.
  • provide them with personalized self-management information and answer their questions about their treatments.
  • giving them online tools (website, Facebook, YouTube, Digital app) to help them follow their treatment.

The benefit is threefold:

  • Increased awareness and adherence through better understanding of their diseases and prescription.
  • Supporting consultation skills for nurses.
  • Physicians are more available to their patients thanks to optimized visits.

Discover our insights on hypertension

Discover our insights on hypertension

Discover our insights on diabetes

Discover our insights on diabetes

Since 2020, Servier Greece has been training hundreds of pharmacists on the difficulties patients face in adhering to their treatment. These trainings, offered under the auspices of the CONCORD initiative (see below), aim to enhance communication between pharmacists and patients so that pharmacists can educate patients on the importance of closely following their treatment.

The results show that regular follow-up by a healthcare professional has a positive impact on therapeutic adherence: between the first month and the fifth, the patient adherence rate, measured by a qualitative questionnaire, increased by more than 20%.2.

Did you know?

The CONCORD* study conducted by Servier’s teams in Greece aimed to demonstrate the effect of an educational program for pharmacists on therapeutic adherence. In 2022, the study evaluated the impact of training 133 pharmacists on the adherence of 1,146 patients over a four-month period. The results showed an average improvement of more than 20%2 in the adherence of patients on the different parameters evaluated.

In Australia, one in ten people is thought to have depression.3 However, studies show that 60% of patients stop following their treatment to the letter within the first three months.4

In the face of poor treatment adherence, Servier Australia have partnered with MedAdvisor SolutionsTM, the world leader in pharmacy-driven patient engagement solutions, to develop a tailored digital program to improve therapeutic adherence for patients suffering from depression.

This program has been a great success, especially thanks to the involvement of all stakeholders. Pharmacies, as the healthcare setting most frequently accessed by patients, have played a crucial role in supporting patients to overcome adherence hurdles.  

Did you know?

In Australia, pharmacists are among the three most trusted healthcare professionals in the eyes of patients6, making the pharmacy an ideal channel for informing patients about their health care process and adherence issues.

Therapeutic adherence in figures:

50%

It is estimated that less than 50% of patients are properly receiving the prescribed monthly treatment7

¼

About ¼ of the drugs prescribed by physicians would never be consumed by patients8

120 billion

The lack of therapeutic adherence would cost about 120 billion euros in Europe.9

Discover “Because I Say So” a global campaign that educates patients with hypertension to better adhere to their treatment.

00:00 / 00:00

[1] MPRsc ≥ 80% – calculated using data from IMS Health’s LifeLink and EPPM databases
[2] CONCORD study “Convince for the monitoring by the Pharmacists of patients with Dyslipidemia, Hypertension and Chronic Venous Disease compliance” (https://pubmed.ncbi.nlm.nih.gov/38106368/
[3] Australian Bureau of Statistics. 2018. National Health Survey: Mental Health. Available from (https://www.abs.gov.au/statistics/health/mental-health/mental-health/2017-18).
[4] Rossom RC, Shortreed S, Coleman KJ, et al. Antidepressant adherence across diverse populations and healthcare settings. Depress Anxiety, 2016; 33: 765–74. (ANTIDEPRESSANT ADHERENCE ACROSS DIVERSE POPULATIONS AND HEALTHCARE SETTINGS – PubMed (nih.gov))
[5] MedAdvisor Solutions (https://www.medadvisorsolutions.com/en-au/#aboutus)
[6] The pharmacy guild of Australia (Pharmacists again top-rated with patients – The Pharmacy Guild of Australia)
[7] Medication Adherence Measures: An Overview – PMC (nih.gov)
[8] Etude Observatoire Jalma, étude Observance (https://www.lemoniteurdespharmacies.fr/ressources/upload/imgnewspha/depot/synthese-observatoire-observance.pdf)
[9] Université de Genève : https://www.unige.ch/lejournal/recherche/printemps-2023/adhesion-traitement/ (consulté en juin 2024)